Search Results

March 27, 2019  

Blue Water Profits on DNA Plays

A biotechnology investor betting on advancements in “precision medicine” is trouncing the competition, both on an absolute and risk-adjusted basis.Through February, Private Wealth Partners’ Blue Water Life Science Fund has generated a 47.9% annualized return since inception in March 2017. The fund’s Sortino ratio — a measure of risk-adjusted returns commonly used to gauge hedge fund performance — is an enviable...

This article is free to subscribers of Hedge Fund Alert. If you are a subscriber, please sign in.

If you are not a subscriber, please complete the form below to purchase the article for $19.95.
First Name *
Last Name *
E-mail *
Card Number *
Expiration *
Card Code *
Address *
City *
State/Province *
Zip/Postal Code *

Purchase Article